As Asia Pacific President at MSD, known as Merck in the US and Canada, Dorthe Mikkelsen is leading the pharma company across some of the world’s fastest-growing and most challenging markets.
Mikkelsen, who is MSD’s first female president in the region and one of very few women leading global pharmaceutical companies in Asia Pacific, is up for the challenge.
An MSD veteran of over 21 years, Mikkelsen says she is still passionate about the science behind MSD’s product portfolio but sees the bigger task to be how to get those medicines and treatments into the hands of healthcare professionals and patients.
“At MSD we’re committed to identifying innovative ways to address rapidly evolving healthcare needs across the Asia Pacific Region,” Mikkelsen tells Business Insider.
A good example is the MSD for Mothers initiative, a $500 million project set up to help prevent vulnerable women from dying during pregnancy and childbirth.
To date, MSD has invested in 12 maternal-health related programs across nine countries in Asia Pacific, reaching more than 2.3 million women and nearly 19,000 healthcare professionals. Efforts in India — one of MSD for Mothers’ priority countries — have helped improve the quality of maternity care for 1 million women.